Back to Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc.

All insiders

14 insiders

InsiderRole% of sharesShares heldLast trade
ORBIMED ADVISORS LLC10% owner8.95%6,555,102Jun 22, 2026
Lyssikatos Joseph PFormerCHIEF SCIENTIFIC OFFICER1.04%758,938Feb 12, 2026
Patel AnishFormerCHIEF OPERATING OFFICER0.32%235,011Feb 12, 2026
Hohl BenjaminFormerCHIEF FINANCIAL OFFICER0.07%51,000Mar 6, 2026
Collins Helen LouiseCHIEF MEDICAL OFFICER0.03%25,000Mar 25, 2026
Heyman Richard A.Director0.03%22,647Feb 17, 2026
Ballal Rahul D.DirectorFeb 12, 2026
Bauer JakeDirectorFeb 12, 2026
Derynck Mika KDirectorFeb 12, 2026
Garland J. ScottDirectorFeb 12, 2026
Gupta RishiDirectorFeb 12, 2026
Kunkel Lori AnneDirectorFeb 12, 2026
OrbiMed Capital GP VII LLC10% owner
OrbiMed Genesis GP LLC10% owner
← PrevPage 1 of 1Next →